Aaron Dulgar-Tulloch

Aaron Dulgar-Tulloch currently serves as Chief Technology Officer for Genomic Medicine and Global Head of Research and Development, Cell and Gene Therapy at Cytiva since April 2020. Previously, Aaron held various leadership roles at GE Healthcare from May 2013 to April 2020, including Global Head of Research and Development and Director of Global Biology and Process Sciences, overseeing significant R&D operations and teams. Aaron has extensive experience in cell therapy development, process services, and strategic initiatives, having successfully built a process development services business from the ground up. Prior roles at GE Research highlighted Aaron's management of interdisciplinary teams in nanotechnology and molecular biology. Aaron earned a B.S.E. in Chemical and Biological Engineering from Princeton University and a Ph.D. in Biomaterials from Rensselaer Polytechnic Institute.